| Symbol |
Name |
|
ABHD12
|
abhydrolase domain containing 12
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
ANXA9
|
annexin A9
|
|
APC
|
adenomatous polyposis coli
|
|
APOA5
|
apolipoprotein A-V
|
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APRT
|
adenine phosphoribosyltransferase
|
|
AQP9
|
aquaporin 9
|
|
ARRB1
|
arrestin, beta 1
|
|
ARRB2
|
arrestin, beta 2
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATXN3
|
ataxin 3
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
B2M
|
beta-2-microglobulin
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CDC25A
|
cell division cycle 25A
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDX2
|
caudal type homeobox 2
|
|
CHGA
|
chromogranin A
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHRNE
|
cholinergic receptor, nicotinic, epsilon (muscle)
|
|
CNNM4
|
cyclin and CBS domain divalent metal cation transport mediator 4
|
|
COL8A2
|
collagen, type VIII, alpha 2
|
|
COMT
|
catechol-O-methyltransferase
|
|
CSE1L
|
CSE1 chromosome segregation 1-like (yeast)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
DBT
|
dihydrolipoamide branched chain transacylase E2
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCLK1
|
doublecortin-like kinase 1
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
EDNRB
|
endothelin receptor type B
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELN
|
elastin
|
|
ENDOG
|
endonuclease G
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBN1
|
fibrillin 1
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
GABRR1
|
gamma-aminobutyric acid (GABA) A receptor, rho 1
|
|
GBA
|
glucosidase, beta, acid
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GPX4
|
glutathione peroxidase 4
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRN
|
granulin
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
H2AFX
|
H2A histone family, member X
|
|
HBB
|
hemoglobin, beta
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH2
|
histamine receptor H2
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IL15
|
interleukin 15
|
|
IL19
|
interleukin 19
|
|
IL1B
|
interleukin 1, beta
|
|
IL20
|
interleukin 20
|
|
IL24
|
interleukin 24
|
|
IL6
|
interleukin 6
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JAK2
|
Janus kinase 2
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LAMP2
|
lysosomal-associated membrane protein 2
|
|
LAT
|
linker for activation of T cells
|
|
LBR
|
lamin B receptor
|
|
LEP
|
leptin
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTB4R
|
leukotriene B4 receptor
|
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1
|
|
LZTFL1
|
leucine zipper transcription factor-like 1
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBNL1
|
muscleblind-like splicing regulator 1
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MED1
|
mediator complex subunit 1
|
|
MIR125A
|
microRNA 125a
|
|
MIR182
|
microRNA 182
|
|
MIR96
|
microRNA 96
|
|
MMAA
|
methylmalonic aciduria (cobalamin deficiency) cblA type
|
|
MMAB
|
methylmalonic aciduria (cobalamin deficiency) cblB type
|
|
MTBP
|
MDM2 binding protein
|
|
MUT
|
methylmalonyl CoA mutase
|
|
MXD1
|
MAX dimerization protein 1
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYP3
|
myopia 3 (high grade, autosomal dominant)
|
|
NANOG
|
Nanog homeobox
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NDP
|
Norrie disease (pseudoglioma)
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NF1
|
neurofibromin 1
|
|
NGB
|
neuroglobin
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPPA
|
natriuretic peptide A
|
|
NRG2
|
neuregulin 2
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PEMT
|
phosphatidylethanolamine N-methyltransferase
|
|
PEX12
|
peroxisomal biogenesis factor 12
|
|
PGR
|
progesterone receptor
|
|
PGRMC2
|
progesterone receptor membrane component 2
|
|
PLEKHO1
|
pleckstrin homology domain containing, family O member 1
|
|
PNLIP
|
pancreatic lipase
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POT1
|
protection of telomeres 1
|
|
PRNP
|
prion protein
|
|
PSEN1
|
presenilin 1
|
|
PSENEN
|
presenilin enhancer gamma secretase subunit
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
QSOX1
|
quiescin Q6 sulfhydryl oxidase 1
|
|
RAB5A
|
RAB5A, member RAS oncogene family
|
|
RHO
|
rhodopsin
|
|
RNASEH2B
|
ribonuclease H2, subunit B
|
|
RNASEH2C
|
ribonuclease H2, subunit C
|
|
S100A8
|
S100 calcium binding protein A8
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SFTPA1
|
surfactant protein A1
|
|
SFTPB
|
surfactant protein B
|
|
SLC1A5
|
solute carrier family 1 (neutral amino acid transporter), member 5
|
|
SLC28A3
|
solute carrier family 28 (concentrative nucleoside transporter), member 3
|
|
SLC39A12
|
solute carrier family 39 (zinc transporter), member 12
|
|
SLC4A1
|
solute carrier family 4 (anion exchanger), member 1 (Diego blood group)
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SNAP23
|
synaptosomal-associated protein, 23kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SPN
|
sialophorin
|
|
SRD5A1
|
steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)
|
|
SSTR2
|
somatostatin receptor 2
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
SYP
|
synaptophysin
|
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TBP
|
TATA box binding protein
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TF
|
transferrin
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TLR4
|
toll-like receptor 4
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TP53
|
tumor protein p53
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TRIM37
|
tripartite motif containing 37
|
|
TRPC1
|
transient receptor potential cation channel, subfamily C, member 1
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TRPV4
|
transient receptor potential cation channel, subfamily V, member 4
|
|
TTBK2
|
tau tubulin kinase 2
|
|
TTN
|
titin
|
|
TUBA1A
|
tubulin, alpha 1a
|
|
TXN
|
thioredoxin
|
|
VIM
|
vimentin
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VTN
|
vitronectin
|
|
WDR81
|
WD repeat domain 81
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
WT1
|
Wilms tumor 1
|